Introduction
============

To clarify the relation between ATP and prostaglandin E~2~(PGE~2~) in the immunologic system, we investigated the acute and chronic effects of PGE~2~on activation of purinergic signaling in monocytes by measuring the ATP-induced elevation of intracellular Ca^2+^(\[Ca\]~i~) in fura-2-loaded THP-1 monocytes.

Method
======

THP-1 monocytes were grown for about 2 days. To examine the chronic effects, PGE~2~and dibutyryl cAMP (dbcAMP) were added and incubated for another day. The cell suspensions were washed, loaded with fura-2-AM, and transferred into a quartz cuvette and placed in the thermostat-regulated sample chamber of a dual excitation beam spectrophotometer. To examine the acute effects, ATP was added immediately after PGE~2~and dbcAMP into the cuvette. In the chronic experiment, ATP alone was added into the cuvette. Fura-2 fluorescence emission was measured at 510 nm. The \[Ca\]~i~was calculated from the ratio of the fluorescence at the two excitation wavelengths.

Results
=======

ATP induced a transient increase in \[Ca\]~i~followed by a sustained elevation of \[Ca\]~i~. Acutely, PGE~2~inhibited both the transient and sustained ATP-induced elevations of \[Ca\]~i~. However, this acute inhibitory effect diminished gradually with time and chronic PGE~2~accelerated the transient and sustained ATP-induced \[Ca\]~i~elevations for 24 hours. Both the acute and chronic effects of PGE~2~were mimicked by dbcAMP. In Ca^2+^-free solution, ATP did not induce the sustained elevation of \[Ca\]~i~in control cells or cells pretreated for 24 hours with dbcAMP. This indicates that the ATP-induced sustained elevation of \[Ca\]~i~was due to Ca^2+^entry. In addition, receptor-operated Ca^2+^channel blockers inhibited the sustained ATP-induced elevation of \[Ca\]~i~in control cells and cells pretreated with for 24 hours dbcAMP.

Conclusion
==========

Acute PGE~2~inhibited the ATP-induced activation of monocytes. On the other hand, chronic PGE~2~accelerated monocyte activation by upregulation of receptor-operated Ca^2+^channels ROCs). If this mechanism exhibits a physiological role, ROC inhibitors should be developed as new anti-inflammatory agents.
